CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 4 Open-market buy Director bought 54,890 shares at an average $1.50 ($82,105)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 1,172 shares (option exercise)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 325,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 100,000 shares (grant or award)
- 4 Exercise or conversion Director acquired 1,172 shares (option exercise)
- 4 Open-market buy Director bought 20,105 shares at an average $1.43 ($28,652)
- 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
- 4 Open-market buy Director bought 50,005 shares at an average $1.37 ($68,441)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 135,000 shares at an average $1.39 ($187,093)
- 4 Open-market buy Director bought 8,000 shares at an average $1.45 ($11,562)
- 4 Open-market buy Director bought 32,000 shares at an average $1.40 ($44,722)
- 4 Open-market buy Director bought 100,000 shares at an average $1.42 ($141,932)
- 4 Open-market buy Director bought 100,000 shares at an average $1.38 ($138,380)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 62,318 shares (to pay taxes)
Page 5 of 22 · 436 filings